Stifel Financial’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.02M | Buy |
454,019
+52,237
| +13% | +$808K | 0.01% | 1068 |
|
2025
Q1 | $5.97M | Sell |
401,782
-33,359
| -8% | -$496K | 0.01% | 1092 |
|
2024
Q4 | $5.76M | Sell |
435,141
-5,525
| -1% | -$73.2K | 0.01% | 1132 |
|
2024
Q3 | $6.27M | Buy |
440,666
+224,594
| +104% | +$3.19M | 0.01% | 1077 |
|
2024
Q2 | $2.8M | Sell |
216,072
-78,143
| -27% | -$1.01M | ﹤0.01% | 1496 |
|
2024
Q1 | $4.09M | Buy |
294,215
+85,772
| +41% | +$1.19M | ﹤0.01% | 1258 |
|
2023
Q4 | $2.97M | Sell |
208,443
-85,370
| -29% | -$1.22M | ﹤0.01% | 1409 |
|
2023
Q3 | $4.55M | Buy |
293,813
+14,766
| +5% | +$228K | 0.01% | 1078 |
|
2023
Q2 | $4.38M | Buy |
279,047
+3,859
| +1% | +$60.6K | 0.01% | 1118 |
|
2023
Q1 | $4.54M | Buy |
275,188
+161,919
| +143% | +$2.67M | 0.01% | 1084 |
|
2022
Q4 | $1.77M | Sell |
113,269
-10,428
| -8% | -$163K | ﹤0.01% | 1608 |
|
2022
Q3 | $1.6M | Buy |
123,697
+15,182
| +14% | +$197K | ﹤0.01% | 1622 |
|
2022
Q2 | $1.52M | Buy |
108,515
+12,679
| +13% | +$178K | ﹤0.01% | 1687 |
|
2022
Q1 | $1.37M | Buy |
95,836
+8,884
| +10% | +$127K | ﹤0.01% | 1891 |
|
2021
Q4 | $1.19M | Buy |
86,952
+10,212
| +13% | +$139K | ﹤0.01% | 1994 |
|
2021
Q3 | $1.26M | Buy |
76,740
+12,178
| +19% | +$199K | ﹤0.01% | 1908 |
|
2021
Q2 | $1.09M | Buy |
64,562
+383
| +0.6% | +$6.44K | ﹤0.01% | 2032 |
|
2021
Q1 | $1.17M | Sell |
64,179
-93,125
| -59% | -$1.7M | ﹤0.01% | 1889 |
|
2020
Q4 | $2.86M | Sell |
157,304
-43,185
| -22% | -$786K | 0.01% | 1163 |
|
2020
Q3 | $3.58M | Sell |
200,489
-4,117
| -2% | -$73.5K | 0.01% | 926 |
|
2020
Q2 | $3.67M | Sell |
204,606
-14,059
| -6% | -$252K | 0.01% | 861 |
|
2020
Q1 | $3.32M | Buy |
218,665
+2,851
| +1% | +$43.3K | 0.01% | 820 |
|
2019
Q4 | $4.26M | Buy |
215,814
+25,649
| +13% | +$506K | 0.01% | 956 |
|
2019
Q3 | $3.27M | Sell |
190,165
-17,891
| -9% | -$308K | 0.01% | 1026 |
|
2019
Q2 | $3.68M | Buy |
208,056
+6,538
| +3% | +$116K | 0.01% | 987 |
|
2019
Q1 | $4.1M | Buy |
+201,518
| New | +$4.1M | 0.01% | 893 |
|